ACADIA Pharmaceuticals Inc (ACAD) earnings · P/E 15, rev $576.0M
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
This ACAD earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
When the next ACAD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for ACAD. We will not invent a beat or miss.
Not investment advice. Full ACAD research stays on the stock page; the tape stays on the quote page.
Not investment advice.